Neuropedia Consult

Williams Syndrome

Introduction

Williams syndrome, as a neurodevelopmental disorder, was first described in 1961 by the New Zealand cardiologist J.C.P. Williams, who identified a group of children with supravalvular aortic stenosis, intellectual delay/disability, and distinctive facial features. Shortly thereafter, similar observations were reported by Alois Beuren; therefore, the condition is sometimes referred to as Williams–Beuren syndrome.

For several decades, the diagnosis was based solely on clinical recognition, but in the 1990s, advances in molecular genetics led to the identification of a characteristic microdeletion on chromosome 7q11.23, providing a genetic explanation for the syndrome.

Epidemiology

Williams syndrome has a prevalence of 1 in 7,500 to 1 in 20,000 live births. It affects males and females and occurs across all ethnic and geographic populations. Most cases arise sporadically due to de novo chromosomal microdeletions, although autosomal-dominant familial transmission has been reported in rare cases. The condition is likely underdiagnosed, particularly in individuals with milder phenotypes.

WS is caused by a heterozygous microdeletion between 1.5-1.8 Mb on chromosome 7q11.23, encompassing 25–28 genes. This deletion typically includes the ELN (elastin) gene, which encodes elastin and is critical for the integrity and elasticity of blood vessels, explaining the characteristic cardiovascular manifestations. The deletion arises from unequal recombination mediated by low-copy repeat sequences in the region. In most individuals, the deletion occurs de novo. However, in inherited forms, it follows an autosomal dominant pattern with a 50% risk in the next generation. The multisystem phenotype reflects the combined effects of haploinsufficiency of several genes within the deleted region.

Pathophysiology

The pathophysiology of Williams syndrome is complex and results from the combined effects of reduced expression of multiple genes within the deleted chromosomal region. Haploinsufficiency of the ELN gene leads to abnormalities in connective tissue and vascular structure, particularly narrowing of medium- and large-sized arteries, most notably supravalvular aortic stenosis. Other genes involved in neurodevelopmental and cognitive features affect neuronal development, synaptic function, and brain connectivity. Structural and functional CNS differences have been identified, which include altered development of the parietal and occipital regions. This may underlie the characteristic cognitive profile with relative strengths in verbal abilities and weaknesses in visuospatial processing.

Dysregulation of calcium metabolism, endocrine function, and connective tissue integrity also contributes to the multisystem manifestations.

Clinical Manifestations

Williams syndrome manifests a combination of physical, cognitive, and behavioral features in varying degrees. Affected individuals often have characteristic facial features, described as “elfin facies,” including a broad forehead, periorbital swelling, short upturned nose, long philtrum, wide mouth, and full lips. Cardiovascular abnormalities are another hallmark of the condition, with stenosis of the supravalvular aorta, pulmonary artery, and renal artery. Infants frequently present with feeding difficulties, failure to thrive, hypotonia, and irritability. On the other hand, most individuals have mild to moderate intellectual disability, with a distinctive cognitive profile characterized by relatively strong verbal and social skills in contrast to marked deficits in visuospatial function.

Behavioral changes include a friendly and sociable personality, increased empathy, anxiety, attention deficits, ADHD/ADD, and specific phobias. Many individuals can demonstrate hypersensitivity to sound (hyperacusis).

Additional medical features include hypercalcemia in infancy, growth retardation, endocrine abnormalities such as hypothyroidism or precocious puberty, gastrointestinal problems, and musculoskeletal issues, including joint laxity in early childhood followed by muscular stiffness.

The diagnosis of Williams syndrome is suspected clinically and it is based on the characteristic combination of facial features, cardiovascular findings, and neurodevelopmental profile, and is confirmed by genetic testing demonstrating a microdeletion at chromosome 7q11.23. Fluorescence in situ hybridization (FISH) was historically used, but today chromosomal microarray analysis or multiplex ligation-dependent probe amplification (MLPA) is more commonly employed. Differential diagnoses may include other syndromes with developmental delay and congenital heart disease, but the distinct cognitive and behavioral phenotype of Williams syndrome is often helpful diagnostically. Additional evaluations typically include echocardiography to assess cardiovascular involvement, as well as monitoring of calcium levels, thyroid function, and renal status.

There is no curative treatment, and management is multidisciplinary and must be oriented to the individual’s medical and developmental necessities. Cardiovascular abnormalities require regular monitoring and, in some cases, surgical or interventional treatment. Early intervention programs, including physiotherapy, occupational therapy, and speech therapy, are essential for supporting developmental milestones. Educational strategies should account for the uneven cognitive profile, emphasizing language strengths while addressing visuospatial difficulties. Behavioral and psychiatric issues, such as anxiety and attention deficits, may require psychological interventions and, in some cases, pharmacological treatment. Medical management also includes monitoring and treatment of hypercalcemia, endocrine disorders, and gastrointestinal problems, as well as regular follow-up for potential complications.

The prognosis for individuals with WS varies depending on the severity of cardiovascular or systemic involvement. Life expectancy has improved, and many individuals survive into adulthood due to advances in medical care, particularly in cardiology. Intellectual disability is lifelong, but many individuals can develop strong verbal communication skills and build adequate social relationships. However, challenges related to anxiety, diminished adaptive functioning, and independence often persist. Long-term outcomes depend on the extent of medical complications, access to supportive interventions, and ongoing multidisciplinary care, all of which can significantly enhance quality of life.